# Personalized Anticoagulant Therapy for Pulmonary Thromboembolism

> **NCT06341231** · — · RECRUITING · sponsor: **Xiangya Hospital of Central South University** · enrollment: 4700 (estimated)

## Conditions studied

- Pulmonary Thromboembolisms
- Anticoagulants; Increased

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06341231
- **Lead sponsor:** Xiangya Hospital of Central South University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-02-01
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 4700 (ESTIMATED)
- **Last updated:** 2024-04-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06341231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06341231, "Personalized Anticoagulant Therapy for Pulmonary Thromboembolism". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT06341231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*